The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo

Abstract

The p21 gene encodes a cyclin–dependent kinase inhibitor that affects cell–cycle progression, but the potential of this gene product to serve as a tumour suppressor in vivo has not been established. In this report, we show that the growth of malignant cells in vitro and in vivo is inhibited by expression of p21. Expression of p21 resulted in an accumulation of cells in G0/G1, altered morphology, and cell differentiation, but apoptosis was not induced. Introduction of p21 with adenoviral vectors into malignant cells completely suppressed their growth in vivo and also reduced the growth of established pre–existing tumours. Gene transfer of p21 may provide a molecular genetic approach to arresting cancer cell growth by committing malignant cells irreversibly to a pathway of terminal differentiation.

Cite this article

Yang, ZY., Perkins, N., Ohno, T. et al. The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1, 1052–1056 (1995). https://doi.org/10.1038/nm1095-1052

View full text

>> Full Text:   The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo